Literature DB >> 11149616

Polymorphisms in the CAG repeat--a source of error in Huntington disease DNA testing.

S Yu1, A Fimmel, D Fung, R J Trent.   

Abstract

Five of 400 patients (1.3%), referred for Huntington disease DNA testing, demonstrated a single allele on CAG alone, but two alleles when the CAG + CCG repeats were measured. The PCR assay failed to detect one allele in the CAG alone assay because of single-base silent polymorphisms in the penultimate or the last CAG repeat. The region around and within the CAG repeat sequence in the Huntington disease gene is a hot-spot for DNA polymorphisms, which can occur in up to 1% of subjects tested for Huntington disease. These polymorphisms may interfere with amplification by PCR, and so have the potential to produce a diagnostic error.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149616     DOI: 10.1034/j.1399-0004.2000.580607.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Authors:  Jorge Sequeiros; Sara Seneca; Joanne Martindale
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.

Authors:  Galen E B Wright; Jennifer A Collins; Chris Kay; Cassandra McDonald; Egor Dolzhenko; Qingwen Xia; Kristina Bečanović; Britt I Drögemöller; Alicia Semaka; Charlotte M Nguyen; Brett Trost; Fiona Richards; Emilia K Bijlsma; Ferdinando Squitieri; Colin J D Ross; Stephen W Scherer; Michael A Eberle; Ryan K C Yuen; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2019-05-16       Impact factor: 11.025

3.  Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Authors:  Amanda Krause; Claire Mitchell; Fahmida Essop; Susan Tager; James Temlett; Giovanni Stevanin; Christopher Ross; Dobrila Rudnicki; Russell Margolis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-16       Impact factor: 3.568

4.  CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

Authors:  Simon C Warby; Alexandre Montpetit; Anna R Hayden; Jeffrey B Carroll; Stefanie L Butland; Henk Visscher; Jennifer A Collins; Alicia Semaka; Thomas J Hudson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-02-26       Impact factor: 11.025

5.  EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease.

Authors:  Monique Losekoot; Martine J van Belzen; Sara Seneca; Peter Bauer; Susan A R Stenhouse; David E Barton
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

6.  Improved high sensitivity screen for Huntington disease using a one-step triplet-primed PCR and melting curve assay.

Authors:  Mingjue Zhao; Felicia S H Cheah; Min Chen; Caroline G Lee; Hai-Yang Law; Samuel S Chong
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry.

Authors:  Jessica Dawson; Fiona K Baine-Savanhu; Marc Ciosi; Alastair Maxwell; Darren G Monckton; Amanda Krause
Journal:  HGG Adv       Date:  2022-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.